Dynavax Technologies


Dynavax Technologies Stock Quote
$8.82 -$0.17 -1.9%
Price as of August 6, 2020, 4:30 p.m. EDT View Interactive DVAX Charts

A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.

Interactive Chart

News & Analysis: Dynavax Technologies

The Fool has written over 100 articles on Dynavax Technologies.


Market Moves


Is Dynavax Technologies Stock a Buy?

This stock has the potential to break new highs with its key hepatitis B vaccine and emerging vaccine-adjuvant platform for COVID-19 vaccines.

3 Top Stocks Under $10

One is developing a COVID-19 vaccine; the other two are from rebounding industries.